Scarica l'app Stockscreener
187.03
1.43%
-2.72
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché AZN Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Astrazeneca Plc Borsa (AZN) Ultime notizie
AstraZeneca PLC stock (US6549022043): insider sale and oncology spotlight draw investor attention - AD HOC NEWS
Insider Sell: Mani Sharma Sells Shares of AstraZeneca PLC - GuruFocus
AstraZeneca (AZN) officer Sharma Mani sells 11,893 Ordinary Shares in open market - Stock Titan
FTSE 100 Closes Week Upbeat; AstraZeneca Sees Oncology Approval Progress - Yahoo Finance UK
EU regulator backs approval for AstraZeneca's experimental breast cancer pill - Reuters
AstraZeneca and Daiichi cancer drugs clear regulatory hurdles - London South East
AstraZeneca PLC stock (US6549022043): oncology growth and new approvals keep investors watching - AD HOC NEWS
Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor candidates - AstraZeneca
Enhertu recommended for approval in the EU by CHMP for patients with previously treated HER2-positive metastatic solid tumours - AstraZeneca
CT UK Capital underperforms as underweight on AstraZeneca, Shell - marketscreener.com
AstraZeneca plc stock (GB0009895292): Deutsche Bank reiterates Sell despite strong analyst consensus - AD HOC NEWS
AZN Stock Quote Price and Forecast - CNN
AstraZeneca plc stock (GB0009895292): Deutsche Bank reiterates Sell rating as pipeline and US listin - AD HOC NEWS
AstraZeneca PLC stock (US6549022043): analysts update views as pipeline news keeps investors alert - AD HOC NEWS
ASTRAZENECA : Deutsche Bank reiterates its Sell rating - marketscreener.com
AstraZeneca stock holds steady after net debt rises £2.5 billion following dividend payment - Traders Union
Research Alert: CFRA Adds Shares Of Astrazeneca Plc To The Total Return Portfolio - Moomoo
How VEPPANU Approval Frames Expectations For AstraZeneca’s Camizestrant In ESR1 Disease - Yahoo Finance
AstraZeneca plc stock (GB0009895292): Latest catalyst after recent company news - AD HOC NEWS
ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight - GlobeNewswire Inc.
AstraZeneca PLC stock (US6549022043): US drug approvals keep Big Pharma name in focus - AD HOC NEWS
AZN Stock Price and Chart — LSE:AZN - TradingView
AstraZeneca’s Earnings Call Balances Growth and Risk - TipRanks
AstraZeneca plc stock (GB0009895292): oncology momentum and new data keep investors watching - AD HOC NEWS
AstraZeneca plc stock (GB0009895292): US drug approvals keep pharma giant in focus - AD HOC NEWS
AstraZeneca stock (GB0009895292): lung cancer data and Q1 update keep focus on oncology pipeline - AD HOC NEWS
AstraZeneca PLC stock (US6549022043): US drug approvals and oncology milestone keep pipeline in focu - AD HOC NEWS
FDA approves AstraZeneca’s new kind of hypertension drug - BioPharma Dive
Flat trading for AstraZeneca stock as GBX13,902 resistance keeps gains in check - Traders Union
AZN News | ASTRAZENECA PLC (NYSE:AZN) - ChartMill
AstraZeneca plc stock (GB0009895292): US drug approvals trigger milestone payment and fresh attentio - AD HOC NEWS
AstraZeneca’s New FDA Wins Raise Questions On Growth And Valuation - Yahoo Finance
AstraZeneca Scores Key FDA Wins Across Cardiovascular And Oncology PortfoliosAstraZeneca (NYSE:AZN) - Benzinga
New hypertension option as Astrazeneca’s Baxfendy wins FDA nod - BioWorld News
AstraZeneca Gets FDA Nod for New Hypertension Drug Baxfendy - Yahoo! Finance Canada
AstraZeneca CEO Pascal Soriot receives vested share award under performance plan - Investing.com
AstraZeneca (AZN) CEO granted 18,359 shares as performance award vests - Stock Titan
AstraZeneca receives US approval for Baxfendy to treat hypertension By Investing.com - Investing.com Nigeria
AstraZeneca receives US approval for Baxfendy to treat hypertension - Investing.com
AstraZeneca plc stock (GB0009895292): oncology and vaccines stay in focus after latest earnings and - AD HOC NEWS
AstraZeneca (AZN) secures US approval for first-in-class Baxfendy hypertension treatment - Stock Titan
Enhertu gains early breast cancer approvals for AstraZeneca (NYSE: AZN) in US - Stock Titan
The Zacks Analyst Blog Highlights Costco, Coca-Cola, AstraZeneca and Franklin Financial Services - Yahoo Finance
Citi sees buying opportunity at AstraZeneca after recent falls - Sharecast.com
New AstraZeneca drug targets hormone behind stubborn high blood pressure - Stock Titan
AstraZeneca wins US FDA approval for hypertension drug Baxfendy - MSN
AstraZeneca Announce Baxfendy Approval in the US May 18, 2026 - James Sharp & Co.
US regulator greenlights AstraZeneca's blood pressure drug Baxfendy - London South East
AstraZeneca secures US approval for two drugs - Sharecast.com
AstraZeneca stock holds steady as Enhertu FDA approval for early breast cancer balances sentiment - Traders Union
AstraZeneca wins US approval for first-in-class blood pressure drug and expands cancer treatment Enhertu - Proactive financial news
AstraZeneca wins FDA approval for Enhertu in early breast cancer By Investing.com - Investing.com Nigeria
AZN Stock Price, Quote & Chart | ASTRAZENECA PLC (NYSE:AZN) - ChartMill
AstraZeneca gets approval for new drug in the US - Business Post
AstraZeneca to pay $155 million milestone to Daiichi Sankyo after US approvals - marketscreener.com
AstraZeneca And Daiichi Sankyo Secure FDA Approval For Enhertu In Early Breast Cancer - DirectorsTalk Interviews
AstraZeneca's blood pressure drug wins U.S. approval - marketscreener.com
Astrazeneca collaborates with Roche Diagnostics Asia Pacific to help accelerate sustainable ecosystem for advanced pathology in breast and lung cancer - marketscreener.com
Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension - AstraZeneca
PGIM JENNISON RISING DIVIDEND FUND's AstraZeneca PLC(AZN) Holding History - GuruFocus
111 Capital's AstraZeneca PLC(AZN) Holding History - GuruFocus
AstraZeneca plc stock (GB0009895292): FDA approval boosts cancer portfolio and keeps US investors fo - AD HOC NEWS
Daiichi Sankyo, AstraZeneca get US approvals for Enhertu - marketscreener.com
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):